Trypanocide Treatment of Women Infected with Trypanosoma cruzi and Its Effect on Preventing Congenital Chagas

PLoS Neglected Tropical Diseases

Volumn 8, Issue 11, 2014, Pages

  Fabbro, Diana L ^a   Danesi, Emmaria ^b   Olivera, Veronica ^a   Codebó, Maria Olenka ^b   Denner, Susana ^a   Heredia, Cecilia ^b   Streiger, Mirtha ^a   Sosa Estani, Sergio ^b  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

^b Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITRYPANOSOMAL AGENT; BENZNIDAZOLE; NIFURTIMOX;

ADOLESCENT; ADULT; ARTICLE; CHAGAS DISEASE; DISEASE TRANSMISSION; DRUG TOLERANCE; EDEMA; ELECTROCARDIOGRAPHY; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEMAGGLUTINATION; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PREGNANCY; PRURITUS; RASH; RETROSPECTIVE STUDY; SEROCONVERSION; SEROLOGY; CHILD; CLINICAL TRIAL; IMMUNOLOGY; INFANT; NEWBORN; PREGNANCY COMPLICATIONS, PARASITIC; PRESCHOOL CHILD; PREVENTION AND CONTROL; TRYPANOSOMA CRUZI; VERTICAL TRANSMISSION; YOUNG ADULT;

ADOLESCENT; ADULT; CHAGAS DISEASE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; RETROSPECTIVE STUDIES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI; YOUNG ADULT;

EID: 84920484863     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003312     Document Type: Article

References (29)

1. Zaidemberg M, Spillmann C, Carrizo Páez R, (2004) Control de Chagas en la Argentina. Su evolución. Rev Argent Cardiol 72: 375–380.
2. Yadon Z, Schmunis G, (2009) Congenital Chagas disease: estimating the potential risk in the United States. Am J Trop Med Hyg 81(6): 927–933.
3. Brutus L, Schneider D, Postigo J, Delgado W, Mollinedo S, et al. (2007) Evidence of congenital transmission of Trypanosoma cruzi in a vector-free area of Bolivia. Trans R Soc Trop Med Hyg 101: 1159–1160.
4. De Rissio AM, Riarte AR, Garcia MM, Esteva MI, Quaglino M, et al. (2010) Congenital Trypanosoma cruzi infection. Efficacy of its monitoring in an urban reference health center in a non-endemic area of Argentina. Am J Trop Med Hyg 82(5): 838–845.
5. Howard EJ, Xiong X, Carlier Y, Sosa-Estani S, Buekens P. (2013) Frecuency of the congenital transmission of Trypanosoma cruzi: a systematic review and meta-analysis www.bjog.org DOI 10.1111/1471-0528.12396 BJOG.
6. Sosa-Estani S, (2005) Congenital transmissión of Tripanosoma cruzi in Argentina. Rev Soc Bras Med Trop 38(2): 29–32.
7. Basombrío MA, Nasser J, Segura MA, Marco D, Sanchez Negrete O, et al. (1999) La transmisión de la enfermedad de Chagas en Salta y la detección de casos congénitos Medicina (Buenos Aires). 59(2): 143–146.
8. Gurtler RE, Segura EL, Cohen JE, (2003) Congenital transmission of Trypanosoma cruzi infection in Argentina. Emerg Infect Dis 9(1): 29–32.
9. Streiger M, Fabbro D, del Barco M, Beltramino R, Bovero N, (1995) Chagas congénito en la Ciudad de Santa Fe. Diagnóstico y tratamiento. Medicina (Buenos Aires) 55: 125–33.
10. Moya PR, Paolasso R, Blanco S, Lapasset M, Sanmartino C, et al. (1985) Tratamiento de la enfermedad de Chagas con nifurtimox durante los primeros meses de vida. Medicina (Buenos Aires) 45: 553–558.
11. Blanco SB, Segura EL, Cura EN, Chuit R, Tulian L, Flores I, et al. (2000) Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in north-western Argentina. Trop Med Int Health 5(4): 293–301.
12. Sosa-Estani S, Cura E, Velazquez E, Yampotis C, Segura EL, (2009) Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission. Rev Soc Bras Med Trop 42(5): 484–487.
13. Sosa-Estani S, Colantonio L, Segura E, (2012) Therapy of Chagas Disease: Implications for Levels of Prevention. Journal of Tropical Medicine. Volume 2012 Article ID 292138, 10 pages. doi:10.1155/2012/292138
14. Bisio M, Altcheh J, Lattner J, Moscatelli G, Fink V, et al. (2013) Benznidazole treatment of chagasic encephalitis in pregnant woman with AIDS. Emerg Infect Dis 19(9): 1490–2 Doi 10.3201/eid1909.130667.
15. Corrêa VR, Barbosa FG, de Melo Junior CA, D'Albuquerque e Castro LF, de Andrade Junior HF, et al. (2014) Uneventful benznidazole treatment of acute Chagas disease during pregnancy: a case report. Rev Soc Bras Med Trop 47(3): 397–400.
16. Rissio AM de, Scollo K, Cardoni R, (2009) La transmisión madre-hijo del Trypanosoma cruzi en la Argentina. Medicina (Buenos Aires) 69: 529–535.
17. Sosa-Estani, Dri L, Touris C, Abalde S, Dell'arciprete A, et al. (2009) Transmisión vectorial y congénita del Trypanosoma cruzi en las Lomitas, Formosa. Medicina Buenos Aires 69: 424–430.
18. Hermann E T, Truyens C, Vega C, Even J, Rodriguez P, et al. (2004) Congenital transmission of Trypanosoma cruzi is associated with maternal enhanced parasitemia and decreased production of interferon gamma in response to parasite antigens. J. Inf. Dis 189: 1274–1281.
19. Brutus L, Castillo H, Bernal C, Salas NA, Schneider D, et al. (2010) Short Report: Detectable Trypanosoma cruzi parasitemia during pregnancy and delivery as a risk factor for congenital Chagas disease. Am J Trop Med Hyg 83: 1044–47.
20. Bua J, Volta BJ, Velazquez EB, Ruiz AM, Rissio AM, et al. (2012) Vertical transmission of Trypanosoma cruzi infection: quantification of parasite burden in mothers and their children by parasite DNA amplification. Trans R Soc Trop Med Hyg 106(10): 623–8.
21. Ministerio de Salud de la Nación.(2012) Guía para la atención del paciente infectado con Trypanosoma cruzi (Enfermedad de Chagas). Argentina. Agosto 2012.
22. Viotti R, Vigliano C, Armenti H, Segura E, (1994) Treatment of chronic Chagas disease with benznidazole: clinical and serologic evolution of patients with long term follow-up. Am Heart J 127: 151–162.
23. Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, et al. (2006) Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment. Ann Inter Med 144: 724–734.
24. Fernandes CD, Tiecher FM, Balbino MM, Liarte DB, Scholl D, et al. (2009) Efficacy of benznidazol treatment for asymptomatic chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up. Mem Inst Oswaldo Cruz 104(1): 27–32.
25. Fabbro D, Streiger M, Arias E, Bizai M, del Barco M, et al. (2007) Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina) over a mean follow-up of 21 years: pasitological, serological and clinical evolution. Rev Soc Bras Med Trop 40: 1–10.
26. Fabbro de Suasnábar D, Arias E, Streiger M, Piacenza M, Ingaramo M, et al. (2000) Evolutive behavior towards cardiomyopathy of treated (nifurtimox or benznidazole) and untreated chronic chagasic patients. Rev Inst Med Trop Sao Paulo 42: 99–109.
27. Sosa-Estani S, Viotti R, Segura EL, (2009) Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina. Mem Inst Oswaldo Cruz 04 Suppl 1167–80.
28. Bern C, Montgomery SP, (2009) An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 49: e52–e54
29. Lee BY, Bacon KM, Bottazzi ME, Hotez PJ, (2013) Global economic burden of Chagas disease: a computational simulation model. Lancet Infect Dis 13(4): 342–8.